AI summary
L'Oreal's CEO states that weight-loss drugs are significantly impacting beauty and skincare sales, marking a major shift for the industry.
AI-generated summary. Check the original reporting for context and accuracy.
L'Oreal says weight loss drugs are impacting beauty and skin care sales
Source excerpt
This is the available feed excerpt, which may be shortened or in the publisher’s original language.
The beauty giant's CEO says the use of GLP-1s is "a very important phenomenon for us".
About priority
An automated sorting aid based on source trust, keywords, and entities, on a scale of 1–12. High: 9–12; medium: 6–8; low: 1–5. It does not measure urgency, verify reporting, or indicate editorial endorsement.